Institutional shares held 12.9 Million
18.6K calls
1.1K puts
Total value of holdings $155M
$224K calls
$13K puts
Market Cap $217M
18,023,100 Shares Out.
Institutional ownership 71.42%
# of Institutions 101


Latest Institutional Activity in OPRX

Top Purchases

Q1 2024
Divisadero Street Capital Management, LP Shares Held: 1.57M ($19M)
Q1 2024
Essex Investment Management CO LLC Shares Held: 86.7K ($1.05M)
Q1 2024
Rice Hall James & Associates, LLC Shares Held: 402K ($4.85M)
Q1 2024
Mirae Asset Global Investments Co., Ltd. Shares Held: 44.6K ($538K)
Q1 2024
Blair William & CO Shares Held: 783K ($9.44M)

Top Sells

Q1 2024
Kennedy Capital Management, Inc. Shares Held: 320K ($3.86M)
Q1 2024
D. E. Shaw & Co., Inc. Shares Held: 349K ($4.21M)
Q1 2024
G2 Investment Partners Management LLC Shares Held: 373K ($4.5M)
Q1 2024
Exodus Point Capital Management, LP Shares Held: 11.3K ($137K)
Q1 2024
Citadel Advisors LLC Shares Held: 52.2K ($630K)

About OPRX

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.


Insider Transactions at OPRX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
403K Shares
From 21 Insiders
Grant, award, or other acquisition 176K shares
Exercise of conversion of derivative security 227K shares
Sell / Disposition
57K Shares
From 6 Insiders
Payment of exercise price or tax liability 53K shares
Open market or private sale 4K shares

Track Institutional and Insider Activities on OPRX

Follow OptimizeRx Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OPRX shares.

Notify only if

Insider Trading

Get notified when an Optimize Rx Corp insider buys or sells OPRX shares.

Notify only if

News

Receive news related to OptimizeRx Corp

Track Activities on OPRX